Taking a look at what insiders are doing to gauge the Relmada Therapeutics Inc (RLMD)’s direction
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Relmada Therapeutics Inc shares valued at $109,752 were purchased by TRAVERSA SERGIO on Jan 31 ’24. At $4.00 per share, TRAVERSA SERGIO acquired 27,460 shares. The insider’s holdings grew to 244,024 shares worth approximately […]
RLMD’s latest rating updates from top analysts.
Relmada Therapeutics Inc’s recently made public that its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $0.11 million on Jan 31 ’24. In the deal valued at $4.00 per share,27,460 shares were bought. As a result of this transaction, TRAVERSA SERGIO now holds 244,024 shares worth roughly $1.35 million. Then, Ence Chuck bought […]
Relmada Therapeutics Inc (RLMD) Becoming More Attractive for Investors
In a filing, Relmada Therapeutics Inc revealed its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $0.11 million on Jan 31. In the deal valued at $4.00 per share,27,460 shares were bought. As a result of this transaction, TRAVERSA SERGIO now holds 244,024 shares worth roughly $1.66 million. Then, Ence Chuck bought 13,670 […]
A Guide To The Risks Of Investing In Relmada Therapeutics Inc (RLMD)
Relmada Therapeutics Inc’s recent filing unveils that its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $0.11 million on Jan 31. In the deal valued at $4.00 per share,27,460 shares were bought. As a result of this transaction, TRAVERSA SERGIO now holds 244,024 shares worth roughly $1.36 million. Then, Ence Chuck bought 13,670 […]